Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Radiation Oncology (London, England)
|
October 25, 2018
FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer
Sébastien Thureau, Bernard Dubray, Romain Modzelewski, et al.
Cancers
|
March 29, 2023
Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers
Pierrick Gouel, Françoise Callonnec, Franchel-Raïs Obongo-Anga, et al.
ACS Chemical Neuroscience
|
February 20, 2015
Dihydroquinoline Carbamate Derivatives as "Bio-oxidizable" Prodrugs for Brain Delivery of Acetylcholinesterase Inhibitors: [¹¹C] Radiosynthesis and Biological Evaluation
Pierre Bohn, Fabienne Gourand, Cyril Papamicaël, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 15, 2019
Radiotherapy boost in patients with hypoxic lesions identified by <sup>18</sup>F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up]
Pierre Vera, Sorina-Dana Mihailescu, Justine Lequesne, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 1, 2010
αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in 18F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical study
Nicolas Aide, Mélanie Briand, Pierre Bohn, et al.
Biomolecules
|
March 25, 2020
Development of Novel <sup>111</sup>-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours
Benjamin Poret, Laurence Desrues, Marc-André Bonin, et al.
Cancers
|
August 27, 2021
First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer
Sébastien Thureau, Nicolas Piton, Pierrick Gouel, et al.
Frontiers in Cell and Developmental Biology
|
May 3, 2021
Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma
Vadim Le Joncour, Pierre-Olivier Guichet, Kleouforo-Paul Dembélé, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 4, 2017
Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by <sup>18</sup>F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study)
Pierre Vera, Sébastien Thureau, Philippe Chaumet-Riffaud, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Radiation Oncology (London, England)
|
October 25, 2018
FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer
Sébastien Thureau, Bernard Dubray, Romain Modzelewski, et al.
Cancers
|
March 29, 2023
Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers
Pierrick Gouel, Françoise Callonnec, Franchel-Raïs Obongo-Anga, et al.
ACS Chemical Neuroscience
|
February 20, 2015
Dihydroquinoline Carbamate Derivatives as "Bio-oxidizable" Prodrugs for Brain Delivery of Acetylcholinesterase Inhibitors: [¹¹C] Radiosynthesis and Biological Evaluation
Pierre Bohn, Fabienne Gourand, Cyril Papamicaël, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 15, 2019
Radiotherapy boost in patients with hypoxic lesions identified by <sup>18</sup>F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up]
Pierre Vera, Sorina-Dana Mihailescu, Justine Lequesne, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 1, 2010
αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in 18F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical study
Nicolas Aide, Mélanie Briand, Pierre Bohn, et al.
Biomolecules
|
March 25, 2020
Development of Novel <sup>111</sup>-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours
Benjamin Poret, Laurence Desrues, Marc-André Bonin, et al.
Cancers
|
August 27, 2021
First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer
Sébastien Thureau, Nicolas Piton, Pierrick Gouel, et al.
Frontiers in Cell and Developmental Biology
|
May 3, 2021
Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma
Vadim Le Joncour, Pierre-Olivier Guichet, Kleouforo-Paul Dembélé, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 4, 2017
Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by <sup>18</sup>F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study)
Pierre Vera, Sébastien Thureau, Philippe Chaumet-Riffaud, et al.
Page
of 4